Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Jul 21, 2018 3:16pm
134 Views
Post# 28348981

RE:RE:RE:RE:RE:RE:RE:RE:Information

RE:RE:RE:RE:RE:RE:RE:RE:Information Maybe you shouldnt come to the board assuming nobody has looked at this opportunity from all angles. I've been here for a couple of years and this stock has been dissected from every possible angle by a good number of serious, intelligent people. Maybe all you've read is the past few weeks when there has been an extensive (maybe too much) talk about the recent share price dip. We're all aware of the complexity of the US healthcare system, the difficulties of establishing a drug on the market and the opportunity Thera has.

The issue people had with your initial post is that you specifically talked about an early August report. Sounded like a specific piece of info. So was that BS or did you have a specific report in mind?

Bucknelly21 wrote: I wish I had insider info lol. I just want people that are vested in this like myself to see this from a different perspective with a few more outside facts than just what’s happening with therf directly 


Bullboard Posts